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Shigella flexneri causes a self-limiting gastroenteritis
in humans, characterized by severe localized inflamma-
tion and ulceration of the colonic mucosa. Shigellosis
most often targets young children in underdeveloped
countries. Invasion plasmid antigen C (IpaC) has been
identified as the primary effector protein for Shigella
invasion of epithelial cells. Although an initial model of
IpaC function has been developed, no detailed struc-
tural information is available that could assist in a bet-
ter understanding of the molecular basis for its interac-
tions with the host cytoskeleton and phospholipid
membrane. We have therefore initiated structural stud-
ies of IpaC, IpaC I, (residues 101–363 deleted), and IpaC
H (residues 63–170 deleted). The secondary and terti-
ary structure of the protein was examined as a function
of temperature, employing circular dichroism and high
resolution derivative absorbance techniques. ANS (8-
anilino-1-napthalene sulfonic acid) was used to probe
the exposure of the hydrophobic surfaces under differ-
ent conditions. The interaction of IpaC and these mu-
tants with a liposome model (liposomes with entrapped
fluorescein) was also examined. Domain III (residues
261–363) was studied using linker-scanning mutagene-
sis. It was shown that domain III contains periodic,
sequence-dependent activity, suggesting helical struc-
ture in this section of the protein. In addition to these
structural studies, investigation into the actin nucle-
ation properties of IpaC was conducted, and actin nu-
cleation by IpaC and some of the mutants was exhibited.
Structure-function relationships of IpaC are discussed.
Shigella flexneri causes a self-limiting gastroenteritis called
shigellosis, which is characterized by severe localized inflam-
mation and ulceration of the colonic mucosa (1). An estimated
360,000 Shigella cases occur in the United States each year,
although only 18,000 are reported (2). In developing countries,
the disease is present in most villages. It most commonly
strikes young children and is responsible for an estimated
600,000 deaths/year worldwide (all Shigella spp. combined) (1).
Shigellosis onset involves bacterial invasion of intestinal epi-
thelial cells by a process called “pathogen-induced phagocyto-
sis” (2, 3) and requires the expression of the ipa operon. The
invasion plasmid antigens (or Ipa1 proteins) are effector pro-
teins that are exported by a dedicated type III secretion system
(TTSS) at the host-pathogen interface. There they directly in-
teract with the host cell to promote actin cytoskeleton rear-
rangements at the site of bacterial contact (2). These cytoskel-
etal changes give rise to filopodia, which mature into
membrane ruffles that coalesce to trap the pathogen within a
membrane-bound vacuole (2). The vacuole is then quickly lysed
to provide the bacterium with access to the host cytoplasm,
where it proliferates and is able to directly invade neighboring
cells (4).
IpaC has been identified as the primary effector protein for
Shigella invasion of epithelial cells (5–8). Effector-related func-
tions described for purified IpaC include: (a) enhanced invasion
of cultured cells by S. flexneri (5, 8, 9); (b) induced uptake of
virulence plasmid-cured S. flexneri (5); (c) interaction with
phospholipid membranes (9–11); and (d) triggering of cytoskel-
etal changes in cultured cells (7, 9, 12). Additional activities
associated with IpaC include oligomerization in solution (8),
reconstitution into complexes with IpaB in vitro (8), in vivo
formation of complexes containing IpaB that promote the up-
take of latex beads by cultured cells (6), and reconstitution with
IpaB and IpaD to form a complex that may allow entry of
noninvasive Escherichia coli into cultured cells (13).
It has been demonstrated that IpaC possesses a distinct
functional organization (Scheme I). The immediate N terminus
of IpaC is required for secretion, whereas a region near the N
terminus is responsible for association with IpaB, which is
probably needed for proper presentation of IpaC to the target
cell membrane. The central hydrophobic region of IpaC directs
IpaC penetration of phospholipid membranes and contributes
to interactions with IpaB (14).2 The ability of IpaC to interact
with phospholipid membranes does not require secretion by the
TTSS of S. flexneri (Ref. 9 and this work); however, active
insertion of IpaC into target cell membranes by the TTSS
greatly increases the efficiency of this process (15). The C
terminus of IpaC mediates IpaC-IpaC interactions and proba-
bly possesses IpaC effector function (7, 14). This information,
however, only provides a very general picture of IpaC structure
and function and its role in the S. flexneri infection process.
* This work was supported by an NIGMS, National Institutes of
Health Biotechnology Training Grant to the University of Kansas, a
Bristol Myers Squibb tuition fellowship (to L. A. K.), and NIAID, Na-
tional Institutes of Health funding (Grant AI34428) to (W. D. P.). The
costs of publication of this article were defrayed in part by the payment
of page charges. This article must therefore be hereby marked “adver-
tisement” in accordance with 18 U.S.C. Section 1734 solely to indicate
this fact.
§ These authors contributed equally to this work.
¶ Present address: University of Colorado Health Sciences Center,
School of Pharmacy, 4200 E. 9th Ave., Denver, CO, 80262.
** Present address: Dept. of Molecular Microbiology, University of
Texas at San Antonio, Health Science Center, San Antonio, TX 78229.
‡‡ To whom correspondence should be addressed. Tel.: 785-864-3299;
Fax: 785-864-5294; E-mail picking@ku.edu.
1 The abbreviations used are: Ipa, invasion plasmid antigens; IpaC,
invasion plasmid antigen C; IpaD, invasion plasmid antigen D; ANS,
8-anilino-1-napthalene sulfonic acid; TTSS, type III secretion system;
MEM, minimum Eagle’s medium; SipC, Salmonella invasion protein C.
2 A. Harrington and W. Picking, manuscript in preparation.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 278, No. 5, Issue of January 31, pp. 2792–2798, 2003
© 2003 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.














Unfortunately, there exists no detailed structural information
concerning IpaC that could provide a molecular basis for its
interactions with the host cytoskeleton and phospholipid
membranes.
In this work, we have initiated studies into the structure of
IpaC by employing a number of biophysical approaches. Trun-
cated versions of IpaC, specifically IpaC I (residues 101–363
deleted) and IpaC H (residues 63–170 deleted), were overex-
pressed in E. coli and purified, permitting structural analysis
and a more comprehensive investigation into the role of the
individual domains described above. The interaction of these
mutants and full-length IpaC with a liposome model was also
examined. In addition to these structural studies, an investi-
gation into the actin nucleation properties of IpaC and these
deletion constructs was conducted. Finally, domain III (resi-
dues 261–363), which has previously resisted attempts at pu-
rification after recombinant expression, was studied using an
alternate technique, linker-scanning mutagenesis. From this,
it is shown that domain III contains a sequence periodic struc-
ture-activity relationship, which suggests that the activity may
be dependent on helical structure in this region. Interpretation
of IpaC structure with regard to the functional properties of the
wild-type protein is then discussed.
EXPERIMENTAL PROCEDURES
Materials—DOPC (dioleoylphosphatidylcholine) and DOPG (dio-
leoylphosphatidylglycerol) were purchased from Avanti. ANS (8-ani-
lino-1-naphthalene sulfonic acid) was obtained from Across Organics,
and fluorescein (5,6-carboxyfluorescein, high purity) was obtained from
Molecular Probes. Dialysis materials were provided by Spectra. All
other chemicals were of reagent grade and obtained from Sigma
and Fisher.
Preparation of Affinity-purified Recombinant Proteins—Plasmids
used to prepare recombinant IpaC and IpaC H and sipC have been
described previously (5, 16, 17). pWPI was designed to encode an IpaC
peptide called region I, in which residues 101–363 are deleted. This
plasmid was generated as pWPC15 except that the 3 primer was
designed to place a stop codon at amino acid 101. All new plasmids were
transformed into E. coli BL21(DE3) for high level protein expression.
Recombinant proteins were purified via the N-terminal His6 tag by
nickel chelation chromatography under denaturing conditions as de-
scribed in detail previously (5, 14, 17). Purified proteins were step-
dialyzed against 10 mM NaPO4, pH 7.2, 150 mM NaCl containing 0.5 mM
dithiothreitol to remove the urea.
Sample Preparation—Purified proteins in buffer were stored at
70 °C for long term storage (IpaC only) or 4 °C for short term use (2
weeks). All protein samples were centrifuged at 13,400  g for 5 min at
4 °C on the day of use to remove aggregates formed during storage.
Tween 20 (0.1%) was added to the IpaC solutions to further stabilize
them during freezing. Unfortunately, neither centrifugation nor filtra-
tion was effective at completely removing all aggregated material (ob-
served as a small amount of optical density above 300 nm in absorbance
spectra). Concentrations were therefore obtained employing derivative
absorbance spectroscopy, using N-acetyl-L-tyrosine-ethyl ester deriva-
tive minima at 275 and 283 nm to establish a standard curve since IpaC
possesses no tryptophan residues. Biophysical studies were conducted
in 10 mM NaPO4, 150 mM NaCl, pH 7.2, containing 1 mM dithiothreitol.
Circular Dichroism—CD spectra were recorded with a Jasco J-720
spectrophotometer (Tokyo, Japan) equipped with a Peltier temperature
controller. Far UV spectra (between 195 and 260 nm) were collected
using a 1-mm path length cuvette sealed with a Teflon stopper. A
resolution of 0.1 nm and a scanning speed of 20 nm/min with a 2-s
response time were employed. Spectra presented are an average of six
consecutive spectra. Spectra were recorded at 5 °C intervals employing
a thermostated cuvette holder. An incubation time of 3 min at each
temperature interval (sufficient for equilibrium to be obtained) and a
temperature ramp rate of 20 °C/h were employed. Protein concentra-
tions of 8.3, 26.3, and 11.2 M were employed for IpaC, IpaC I, and
IpaC H, respectively. Noise reduction and data analysis were per-
formed using Standard Analysis and Temperature/Wavelength Analy-
sis programs (Jasco) and MicroCal Origin™ 6.0 software. Secondary
structure content was estimated using the CONTIN (18), SELCON (19),
and CDSSTR (20) analysis programs provided with the CDPro software
suite (21).
Derivative Absorbance Spectroscopy—High-resolution absorbance
spectra were collected on a Hewlett-Packard 8453 UV-Visible spectro-
photometer (Agilent, Palo Alto, CA) fitted with a Peltier temperature
controller. Temperature perturbation studies were conducted at protein
concentrations of 12.7, 25.3, and 16.9 M for IpaC, IpaC I, and IpaC
H, respectively. Spectra were collected for 25 s at 2.5 °C intervals with
a 3-min equilibration time before collection of each spectrum. Spectral
analysis was conducted using UV-Visible Chemstation software (Agi-
lent) and Microcal Origin™ 6.0. Second derivative spectra were calcu-
lated employing a nine-point data filter and fifth degree Savitzky-Golay
polynomial and subsequently fitted to a cubic function with 99 interpo-
lated points/raw data point, permitting 0.01-nm resolution (22). Peak
positions were then determined from the interpolated curves. Optical
density data were simultaneously monitored at 350 nm.
Lipid Interaction Studies—Aliquots of DOPC and DOPG in chloro-
form were dried under nitrogen and vacuum to create thin films of
either 100% DOPC or 50:50 [DOPC]:[DOPG]. Films were hydrated in a
solution containing 100 mM 5,6-carboxyfluorescein at pH 7.0 in water
for 10 min and then sonicated in a bath sonicator for 30 min prior to
extrusion through a 100-nm pore size membrane 10 times at 45 °C. A
final size of 150 nm was determined with a Brookhaven ZetaPALS
dynamic light scattering instrument (Holtsville, NY) equipped with a
25 mW 626-nm laser. Excess dye was separated from the bulk liposomes
by size exclusion chromatography, employing a Sephadex G-25 column
coupled to an AKTA FLPC (Amersham Biosciences). The run buffer was
10 mM NaPO4, 150 mM NaCl, pH 7.4. Peak fractions were collected and
pooled, and lipid content was determined by a total phosphorous assay,
as described (23). Solutions were stored at 4 °C and protected from
light.
Time-based release studies were conducted with a PTI Quanta-
Master spectrophotometer with a thermostated cuvette holder. Sam-
ples were excited at 492 nm, and the emission signal was monitored at
517 nm for 10 min. Excitation slits were set at 1 nm, and emission was
set at 2 nm. Data points were collected at 0.2-s intervals. Data were
collected as follows: buffer was incubated for 3 min at the desired
temperature prior to adding liposome solutions. Baseline fluorescence
was monitored with liposomes alone for 10 min to determine residual
release of fluorescein from the liposomes. Maximum fluorescein release,
as defined by release in the presence of 0.1% Triton, was determined by
adding Triton to the liposome solution 3 min after the start of signal
collection. Protein-induced fluorescein release was examined by moni-
toring the fluorescein signal at 512 nm after addition of protein to the
liposome solution after 3 min of incubation. Both protein and Triton
solutions were added during continuous signal collection through a
syringe port in the sample compartment. The protein concentration
employed was 1 M, and the total lipid concentration was 100 M.
Release was monitored at 10, 20, 30, 35, 40, 45, 50, and 60 °C. Samples
were measured in triplicate. The extent of release was calculated as a
percentage of Triton-induced release at 600 s after background
correction. Analysis was conducted using Felix (PTI) and MicroCal
Origin™ software.
Assay for Actin Nucleation—The fluorescence of pyrene-labeled G-
actin monomers increases following assembly into pyrene F-actin (24).
For monitoring IpaC-mediated actin nucleation in vitro, pyrene G-actin
was incubated at 4 °C in G-actin buffer (5 mM Tris-HCl, pH 8.0, 0.1 mM
ATP, 0.2 mM CaCl2). Test protein (IpaC or an IpaC mutant) was then
added to the sample, and pyrene fluorescence was monitored at 23 °C.
A Spex FluoroMax instrument (Jobin Yvon Horiba, Edison, NJ) was
used to measure pyrene fluorescence using a time-based acquisition
mode with an excitation wavelength of 330 and an emission wavelength
of 385 nm. After 15 min, 50 actin polymerization buffer (100 mM
MgCl2, 50 mM ATP, 2.5 M KCl) was added, and the change in pyrene
fluorescence was monitored as a function of time. Negative controls
either contained no added protein or contained IpaD, which has no
actin-nucleating activity. SipC from Salmonella typhimurium, which
SCHEME 1. Functional organization of IpaC. The N terminus of
IpaC harbors sequences for TTSS export and interaction with IpgC and
IpaB. The central hydrophobic region is involved in IpaB binding, IpaC
penetration of phospholipid membranes, and possibly protein stabiliza-
tion. The C terminus possesses essential oligomerization and effector
functions. Residues 101–363 are deleted in IpaC I ,and residues 63–170
are deleted in IpaC H.














has been shown to nucleate actin in vitro, was used as a positive control
(24).
Linker-scanning Mutagenesis—Linker-scanning mutagenesis was
used to introduce consecutive site-specific mutations into a predicted
coiled-coil segment near the C terminus of IpaC. Either NheI cleavage
sites encoding Ala-Ser pairs or XhoI sites encoding Leu-Glu pairs were
generated throughout the length of the putative coiled-coil region (ami-
no acids 309–344). Primers with a 5 NheI or XhoI site and the appro-
priate neighboring ipaC sequences running in either direction were
used for inverse PCR. The product was digested with NheI or XhoI,
respectively, and then ligated. The resulting plasmids were electropo-
rated into the S. flexneri IpaC mutant strain SF621, and the ability to
restore invasion and contact hemolysis functions was determined as
described below.
S. flexneri Invasion of Cultured Cells and Contact-mediated Hemol-
ysis—S. flexneri invasion of Henle 407 cells was monitored using a
standard gentamycin protection assay as described (16). Semiconfluent
monolayers of Henle 407 cells were seeded into 24-well plates and
grown overnight. SF621 harboring the desired plasmid was grown in
trypticase soy broth containing 100 g/ml ampicillin and 50 g/ml
kanamycin to an A600 of 0.4–0.6. The bacteria were diluted with serum-
free MEM containing 0.45% glucose (MEM-glc), centrifuged onto the
surface of semiconfluent Henle 407 monolayers, and incubated with the
cells for 30 min at 37 °C. Free bacteria were removed by aspiration, and
the cells were washed with MEM containing 5% calf serum and 50
g/ml gentamycin. The cells were incubated in the final gentamycin
wash for 2 h (to kill adherent, noninternalized bacteria) and rinsed with
MEM-glc. The cells were lysed by overlaying them with 250 l of 0.5%
agarose in water. The agarose was then overlaid with 0.5% agar con-
taining 2 LB medium. After overnight incubation at 37 °C, internal-
ized bacteria formed subsurface colonies that were quantified using a
ChemiImager 4400 system (Alpha Innotech Corp., San Leandro, CA).
RESULTS
Statistics—All errors are reported as standard error (S.E.,
n  3) unless otherwise indicated.
Spectroscopic Analysis of Full-length IpaC, IpaC I, and
IpaC H—To better understand the function of IpaC in the
S. flexneri invasion process, a series of structural studies were
conducted to characterize the secondary and tertiary structure
of full-length IpaC, IpaC I, and H mutants and their response
to temperature. All three proteins are efficiently secreted by
the S. flexneri SF621 TTSS and are able to interact with IpaB,
indicating that biological functions associated with the N ter-
minus remain intact (14).
The CD spectrum of IpaC at 20 °C exhibits minima at 222
and 204 nm, suggesting the presence of some helical structure
(Fig. 1A). Secondary structure estimates indicate that IpaC
contains a mixture of -helical and -sheet structure with
significant turn and random structure also present (Table I). In
contrast, IpaC I and IpaC H appear to be less structured, as
indicated by a decrease in CD intensity above 210 nm. The
spectrum of IpaC I exhibits an increase in negative intensity
near 200 nm, suggesting increased random structure. Solution
conditions prevented collection of data below 200 nm, prevent-
ing secondary structure estimation for both mutants. IpaC
undergoes a significant change in secondary structure at fairly
moderate temperatures (Table I and Fig. 1). This transition
suggests a loss of helix content (Table I) and has a midpoint of
43.3  0.3 °C (n  3). In contrast, IpaC I and IpaC H display
evidence of only weak transitions between 10 and 40 °C. Al-
though limited aggregation of some samples was observed
above 30 °C, no red shifts or strong decreases in intensity
indicative of absorption flattening were observed, indicating
that the spectral changes are not an artifact of aggregation-
dependent phenomena.
Because IpaC lacks tryptophan residues, derivative absorb-
ance spectroscopy was employed to monitor tertiary structure
changes. This method is especially useful in aggregating sys-
tems since it is not sensitive to broad spectral components such
as light scattering (25). The spectra display two phenylalanine
(Fig. 2, A and B, 253 and 260 nm) and three tyrosine (Fig. 2,
C–E, 268, 276, and 285 nm) minima (22). Most plots of peak
position versus temperature show similar linear increases with
temperature, which is an intrinsic property of the aromatic
amino acids.3
However, deviations from these linear plots consistent with
structural alterations are observed in many cases. The IpaC
Phe minimum at 253 nm is shifted to longer wavelengths
relative to the two mutants and shows no temperature depend-
ence at lower temperatures. Upon reaching the temperature at
which the protein begins aggregating, the noise in the data
3 L. A. Kueltzo and C. R. Middaugh, manuscript in preparation.
FIG. 1. Circular dichroism analysis of IpaC and its mutants. A,
CD spectrum of IpaC and mutants at 20 °C. Protein concentrations
were 8.3, 26.3, and 11.2 M for IpaC, IpaC I, and IpaC H, respectively.
Spectra were collected at a rate of 20 nm/min employing a resolution of
2 nm. Spectra presented are an average of three consecutive spectra.
The buffer used was 10 mM phosphate, 150 mM NaCl, and 1 mM
dithiothreitol, pH 7.2. B–D, temperature dependence of the molar ellip-
ticity at 222 nm of IpaC, IpaC I, and IpaC H. A major loss in ellipticity
is observed for the full-length IpaC with a Tm of 43.3  0.3 (n  3).
Spectra were recorded at 5 °C intervals employing an incubation time of
3 min at each temperature interval and a temperature ramp rate of
20 °C/h. All other experimental conditions are as in panel A.
TABLE I
Secondary structure estimates for IpaC
Temperature -Helix -Sheet Turn Random
% % % %
20 °C 10 (2)a 34 (1) 22 (2) 32 (2)
40 °C 7 (1) 35 (2) 23 (2) 35 (1)
60 °C 4 (0) 38 (2) 23 (2) 33 (0)
a Errors are reported as S.E., n  3.














begins to increase. The second Phe minimum shows a differ-
ence in minimum position for each of the proteins with the
IpaC peak once again at the longest wavelength. An expanded
version of the IpaC I data (Fig. 2F) shows that IpaC I actually
undergoes a small but very reproducible transition between 30
and 55 °C. The 267 nm IpaC I tyrosine minimum is observed
at longer wavelengths, disappearing from the derivative spec-
trum at temperatures above 62 °C. Two strong transitions are
observed in the plot of the 276-nm tyrosine minimum of IpaC
with no similar transitions seen for either mutant. The 284-nm
IpaC I and IpaC H tyrosine minima again manifest no evi-
dence of conformational change, whereas the IpaC absorption
band shows evidence of the two transitions and is again present
at a longer wavelength (Fig. 2E).
Trends in protein-associative behavior can be seen by mon-
itoring the turbidity (OD) at 350 nm as the temperature is
increased (Fig. 3). Full-length IpaC shows a large change in
turbidity starting near 30 °C. Transitions are observed be-
tween 30 and 70 °C and above 70 °C. Although the changes are
small, a distinct transition is observed starting at 55 °C for
IpaC I, whereas IpaC H shows a small but steady increase in
OD starting at 20 °C (Fig. 3, bottom panels). Both results are
consistent with the formation of soluble aggregates.
Full-length IpaC but Not the IpaC Mutants Interacts with
Liposomes—The effect of IpaC, IpaC I, and IpaC H upon
fluorescein-containing liposomes was examined as a function of
the temperature and lipid composition. Fluorescein can be se-
questered in liposomes at concentrations that produce self-
FIG. 2. Wavelength of the derivative absorbance peaks of IpaC and mutants as a function of temperature. Second derivative
absorbance minima arising from phenylalanine (A and B) and tyrosine (C–E) residues. IpaC (closed squares), IpaC I (open circles), and IpaC H
(open triangles) are shown. F, expanded view of phenylalanine peak 2 position for IpaC I showing a subtle deviation from linearity between 30
and 60 °C. Protein concentrations were 12.7, 25.3, and 16.9 M for IpaC, IpaC I, and IpaC H, respectively. Spectra were collected for 25 s at 2.5 °C
intervals with a 3-min equilibration time before collection of each spectrum. Error bars that are not visible are buried within the symbol.
FIG. 3. Turbidity of ipaC and mutants as a function of temper-
ature. Top, IpaC, IpaC I, and IpaC H. WT, wild type. Bottom, ex-
panded view of IpaC I and IpaC H. Experimental conditions are
described in the legend for Fig. 2.














quenching (26). Any interaction of a protein with such loaded
liposomes that is sufficient to significantly perturb the bilayer
should cause a leakage of the fluorescein, leading to its dilution
and an increase in the fluorescence intensity of the fluorescein
dye. Using this approach, two types of vesicles were employed:
100% DOPC, producing a neutral surface charge, and 50:50
[DOPC]:[DOPG] to produce an overall negatively charged
surface.
The extent of dye release at 600 s at different temperatures
is shown in Fig. 4. No release is observed for IpaC I and IpaC
H. IpaC shows little release at low temperatures with DOPC
liposomes, but a dramatic increase is observed at 30 °C and
higher. Release at lower temperatures is greater with DOPC:
DOPG liposomes. The rate of release is similar to that of the
Triton control (results not illustrated). The liposomes remained
above the phase transitions of the component lipids (20 and
18 °C for DOPC and DOPG, respectively (27)) under all con-
ditions examined.
Linker-scanning Mutagenesis Indicates That the IpaC C Ter-
minus Is Important for Directing Uptake by Cultured Cells—
The region between amino acids 309 and 344 of IpaC is pre-
dicted to possess a coiled-coil trimerization domain based on
primary structure analysis (28). Attempts to purify a recombi-
nant form of this region have been unsuccessful, so a structural
analysis of this region was conducted using linker-scanning
mutagenesis. Initially, XhoI linkers were used to substitute
Leu-Glu amino acid pairs for existing amino acids in this region
of IpaC. Sequence periodicity in the generation of inactivating
mutations with respect to restoring invasiveness to S. flexneri
SF621 was consistent with the presence of a coiled -helix in
this region (Fig. 5A). Although linker-scanning mutations near
the C-terminal end of the putative coiled-coil show periodicity
in reducing invasiveness, they do not eliminate IpaC activity
completely. In contrast, when NheI linkers (encoding Ala-Ser)
were introduced into the same region, substitution for the
Leu335-Ile336 pair did completely eliminate IpaC invasion func-
tion, as did substitution for Leu339-Leu340 (Fig. 5B). This dif-
ference in the effect of amino acid substitutions at this location
could be explained by the fact that the Leu-Glu led to the
replacement of a nonpolar pair of amino acids by a nonpolar/
polar pair. On the other hand, NheI scanning results in the
replacement of nonpolar residues by a polar pair. In total, these
data are consistent with the presence of an -helix within this
portion of IpaC.
Because a single amino acid change at Ile336 and Leu340 in
the putative IpaC coiled region only partially reduced the abil-
ity of IpaC to restore invasiveness, other single amino acid
changes were introduced, using Pro as the substituted amino
acid because of its incompatibility with -helix formation.
When Pro was used to replace Ser314 at the N terminus of the
putative IpaC coil, invasion function was not affected. Replace-
ment of Lys326 reduced IpaC invasion function to less than half
that of native IpaC (Table II). When Ile336 was replaced with
Pro, however, IpaC invasion function was reduced more than
80% (Table II). During linker-scanning analysis, the equivalent
of a single amino acid change at this position (Ile3363 Glu336)
resulted in only a 48% reduction. Replacement of Leu340 with
Pro completely eliminated IpaC invasion function, whereas
replacement with Glu only reduced invasion function 64% (Ta-
ble II). The large negative effect of Pro replacement of amino
acids near the C terminus of the putative IpaC coiled region,
when compared with Glu substitution, is consistent with this
region existing as a functionally important -helix.
IpaC Nucleates Actin in Vitro—It has been reported that the
IpaC homologue from S. typhimurium (SipC) nucleates actin in
vitro (24). We find that IpaC also nucleates actin in vitro with
an efficiency that is at least equal to that of SipC (Fig. 6).
FIG. 4. Release of fluorescein from liposomes after interaction
with IpaC and mutants at various temperatures. Release is meas-
ured as percentage of maximum release in the presence of 0.1% Triton.
Protein concentration was 1 M for all cases, and total lipid concentra-
tion is 100 M. Liposomes were comprised of 100% DOPC or a 50:50
molar mix of DOPC and DOPG.
FIG. 5. Linker-scanning mutagenesis of the putative coiled-
coil region of IpaC. In A, Leu-Glu amino acid pairs, encoded by xhoI
restriction sites, were used to replace existing amino acids. In each case,
the number given is that of the first amino acid being replaced. In B, the
same experiment was carried out using nheI restriction sites, which
encode Ala-Ser pairs. AS313 and AS321 were not generated because the
nheI site would have replaced codons already specific for Ala-Ser pairs.
Invasion is shown relative to that directed by native IpaC using a
standard gentamycin protection assay. The data shown are the average
of triplicates  S.E.














Deletion of the IpaC N terminus does not affect this activity,
whereas deletion of the C terminus (data not shown) or hydro-
phobic region does eliminate the ability of IpaC to nucleate
actin (Fig. 6). Furthermore, the C-terminal addition of a 15-
residue tag that eliminates IpaC effector function in vivo also
eliminates the ability of IpaC to direct actin nucleation (data
not shown), indicating that the C terminus of IpaC is required
for actin nucleation.
DISCUSSION
IpaC is an essential participant in the invasion process of
S. flexneri (3). It is involved in actin rearrangements, pathogen
entry into phagosomal vacuoles, and the subsequent lysis of
those vacuoles (2, 4). Although the broad functional organiza-
tion of IpaC has been described (14, 29), little is known of the
structure of the protein. We find that under physiological con-
ditions, recombinant IpaC is composed of an -helix (10%), a
-sheet, and significant random structure (Table I). Thus, this
protein may be considered a member of that recently recog-
nized class of proteins whose native state contains a significant
amount of disordered structure (30, 31).
Temperature perturbation studies show that IpaC under-
goes a distinct structural transition involving both secondary
and tertiary structure between 30 and 60 °C (Figs. 1 and 2).
This does not involve complete unfolding since the majority of
secondary structure is retained post-transition (Table I). Addi-
tionally, shifts in the derivative absorbance minima to shorter
wavelengths, which would indicate exposure of buried aromatic
resides to bulk solvent, were not observed. This conformational
change is presumably related to temperature-induced aggrega-
tion of IpaC, as detected by turbidity measurements (Fig, 3,
top). Two transitions are observed, the first between 30 and
70 °C and the second above 70 °C. This is consistent with the
initial formation of soluble aggregates followed by more exten-
sive aggregation and with previous observations that IpaC
forms oligomers in solution (8). IpaC homotypic interaction
involving the central hydrophobic region have also been de-
tected using yeast two-hybrid analysis (32). The biologically
relevant oligomerization state of IpaC is currently under
investigation.
Examination of the N-terminal region of IpaC (IpaC I)
shows reduced structural content in comparison with the wild-
type protein. This is accompanied by a reduced effect of tem-
perature on the protein. IpaC I exhibits a small change in
secondary structure above 30 °C (Fig. 1C), as well as a small
tertiary structure transition between 30 and 60 °C (Fig. 2F).
Differences in the environment of the aromatic residues of IpaC
I, detected as shifts in derivative absorbance wavelength when
compared with that of IpaC, are also observed. These shifts
may also reflect differences in aromatic amino acid content.
IpaC contains three Phe residues, whereas only one is present
in IpaC I. Some limited oligomerization is also observed above
50–55 °C in this form of the protein (Fig. 3).
IpaC H (residues 63–170 deleted) possesses significantly
less ordered structure than IpaC, verging on a completely dis-
ordered conformation as shown by the shift of the CD minima
from 204 to 200 nm (Fig. 1A). No major temperature-depend-
ent structural changes are observed for IpaC H, although
slight aggregation is apparent at higher temperatures. Thus,
much of the disordered structure seen in the complete protein
may be reflected in the behavior of this mutant.
The C terminus region of IpaC appears to contain the coiled-
coil region postulated to contribute to IpaC self-interaction and
effector function. Linker-scanning analysis provides an indirect
picture of this region. A periodicity in loss of invasion activity is
observed with different amino acid substitutions, which is con-
sistent with functionally significant helical structure in this
region (Fig. 5). Additional substitutions of proline residues,
known helix breakers, also reduce invasion activity, further
supporting this hypothesis.
During IpaC-mediated Shigella invasion of epithelial cells,
IpaC is inserted into the host cytoplasmic membrane and,
following uptake, mediates vacuolar escape (16), possibly by
disrupting the phospholipid membrane following penetration
(11). Previous studies have indicated that the ability to pene-
trate and disrupt liposomes occurs optimally when the lipid
bilayer possesses a net negative charge (11). We find, however,
that although interactions are enhanced in the presence of
negatively charged liposomes, IpaC also causes low level dis-
ruption of neutral liposomes. The mechanism of disruption
does not appear to be purely a detergent effect since at low
temperatures and in the presence of neutral liposomes, the rate
and extent of fluorescein release is much less than that ob-
served by Triton disruption of liposomes. A strong temperature
dependence is observed for the IpaC-liposome interaction for
both lipid compositions. With negatively charged liposomes,
the extent of release increases until the temperature reaches
TABLE II
The effect of site-specific proline residues within the predicted
coiled-coil of IpaC on invasion function
Site-specific mutation Relative invasion restoreda
None 100  15%
Ile336 3 Glu (LE335)b 52  6%
Leu340 3 Glu (LE339)b 36  8%
Ser314 3 Pro 100  14%
Lys326 3 Pro 47  5%
Ile336 3 Pro 16  3%
Leu340 3 Pro 1  0.3%
a Invasion was tested using a standard gentamycin protection assay.
The data shown are from one representative experiment performs in
triplicate  S.E.
b The single amino acid substitutions were generated as part of the
linker-scanning analysis using XhoI sites. LE335 replaced Leu335-
Ile336 with a Leu-Glu pair, and LE339 replaces Leu339-Leu340 with a
Leu-Glu pair.
FIG. 6. Actin nucleation was determined by incubating py-
rene-actin with protein for 15 min followed by adding actin
polymerization buffer. Actin polymerization is monitored as an in-
crease in pyrene fluorescence as a function of time, and this rate is
greatly accelerated by actin-nucleating proteins such as SipC or IpaC
relative to proteins that do not nucleate actin such as IpaC I or in the
absence of added protein. Deletion of the IpaC C terminus (amino acids
171–363) also eliminates its actin nucleation activity (data not shown),
whereas deletion of the N terminus up to amino acid 62 (IpaC I) does
not affect actin nucleation activity. Data shown are representative of
multiple experiments. AU, arbitrary units.














30 °C, at which point IpaC is nearly as effective in dye release
as Triton. In contrast, neutral liposomes exhibit a sigmoidal
temperature dependence in the release process. This may re-
flect the structural change occurring between 30 and 60 °C in
IpaC, which may produce a more “penetration-efficient” form of
IpaC. Alternatively, the concurrent aggregation process occur-
ring in this temperature range may reflect the ability of oli-
gomerized protein to disrupt the bilayer.
Neither IpaC I nor IpaC H was able to disrupt liposomes.
This is consistent with previous findings that the IpaC hydro-
phobic region is needed for association with Langmuir phos-
pholipid monolayers (9). Coupled with the potential importance
of the central hydrophobic region of IpaC for its overall stabi-
lization, it is possible that this region contributes to overall
tertiary structure stabilization, but when partially exposed, it
directs penetration of phospholipid membranes. This is consist-
ent with the results of ANS binding experiments in which
titrations of IpaC with ANS at 40 °C demonstrate interaction of
the dye with IpaC, indicating that hydrophobic regions of the
protein become exposed under membrane-interactive condi-
tions (not illustrated). As expected, little binding of ANS to the
two mutants is seen over a wide temperature range.
IpaC H and IpaC I fail to nucleate actin in vitro, whereas
IpaC and IpaC I nucleate actin efficiently (Fig. 6). This sug-
gests that actin nucleation requires sequences at the IpaC C
terminus; however, it is possible that conformational changes
induced by mutations at the C terminus are responsible for this
loss of activity. The IpaC C terminus contains a sequence
predicted to form a coiled-coil that may be required for effector
function. From these observations and linker-scanning studies
that reinforce the coiled-coil hypothesis, it seems reasonable to
conclude that this helical conformation is important for some
aspect of actin nucleation. This is supported by preliminary
data that the purified linker-scanning mutant AS339, which
cannot direct S. flexneri invasion of cultured cells, is also un-
able to nucleate actin in vitro (not illustrated).
An analogous ability to nucleate actin was described for SipC
of S. typhimurium (24); however, SipC has not been shown to
act as a “direct effector” in Salmonella invasion. It was recently
reported that SspC (SipC) from S. typhimurium co-purifies
with HeLa cell actin in immunoprecipitation assays, but this
relationship may be mediated by interactions with keratin 8
(33). Deletions introduced at the SspC C terminus and point
mutations near its C terminus (most notably a Leu to Pro
mutation) eliminate its ability to restore invasiveness to a
Salmonella SspC mutant (33), suggesting similar structure-
function relationships for the C termini of IpaC and SspC-
(SipC). How such mutations affect the ability for SspC/SipC to
nucleate actin are not known, but this warrants further study.
In the same report, mutations at the C terminus of SspC
caused the protein to no longer associate with HeLa cell mem-
branes following incubation with S. typhimurium (33). How
similar mutations influence the ability of IpaC to disrupt lipo-
somes has yet to be determined.
As with Salmonella, the role of actin nucleation in invasion
by S. flexneri is not immediately obvious. It is possible that
IpaC-mediated actin nucleation: 1) contributes to the localiza-
tion of actin polymerization in host cells (34, 35) or 2) permits
the quick burst of actin polymerization needed for rapid entry.
It is also possible that actin nucleation by IpaC has a more
direct role in Shigella invasion. A recent report demonstrates
that a cdc42 knockout fibroblast-like cell line is still invaded by
S. flexneri, albeit only at 15% of the levels seen in wild-type
cells (36). Whatever its precise role, the IpaC protein is a key
element in the invasion process of S. flexneri and may provide
an important therapeutic target.
In conclusion, this work presents the first structural analysis
of IpaC, based on the functional organization scheme presented
previously (14). IpaC appears to be partially disordered with
conformational lability increasing under physiological temper-
ature. The existence of a helical domain at the C terminus of
the protein, deemed necessary for effector function in the inva-
sion process, is probed, and the presence of such a structure is
strongly supported. Additionally, the interaction of IpaC with
phospholipid bilayers is further characterized, and distinct do-
mains of the protein are identified as necessary for this inter-
action. Finally, in vitro actin nucleation is demonstrated for
IpaC, and this activity is preliminarily localized to the
C terminus.
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